Wellgistics Health, Inc.
Key Highlights
- Wellgistics Health, Inc. operates as a public company, trading on The NASDAQ Capital Market under the ticker symbol WGRX.
- The company benefits from reduced reporting requirements and increased flexibility as both a 'Smaller reporting company' and an 'Emerging growth company'.
- This status allows for streamlined financial reporting, such as presenting two years of financial reports instead of three, and delayed adoption of new accounting rules.
Financial Analysis
Wellgistics Health, Inc. Annual Report - How They Did This Year
This report reviews Wellgistics Health, Inc.'s performance, covering the past year's finances and operations. You'll find key insights into the company's current status and future.
This report covers the company's performance for the year ending December 31, 2025, representing their most recent full year of operations.
You'll find Wellgistics Health, Inc. trading on The NASDAQ Capital Market under the ticker symbol WGRX.
It's helpful to know the company is classified as both a "Smaller reporting company" and an "Emerging growth company." This means Wellgistics is still a smaller company and benefits from fewer reporting rules compared to larger, more established public companies.
A "Smaller reporting company" typically has less than $250 million in public shares or less than $100 million in yearly sales. If sales are under $100 million, its public shares must be zero or under $700 million.
An "Emerging growth company" (EGC) has total yearly sales under $1.235 billion, based on its last full financial year. This EGC status gives Wellgistics some flexibility. For example, it can show two years of official financial reports instead of three, skip some details about executive pay, and wait longer to follow new accounting rules.
As of mid-2025, the value of shares available to the public was about $27.1 million. These are shares not owned by insiders. This value helps us understand their market size and classification.
As of March 6, 2026, 105.85 million shares of the company's common stock were available. This number is important for calculating the company's total value when combined with the share price, and for understanding per-share metrics like profit per share.
Risk Factors
- As a 'Smaller reporting company' and 'Emerging growth company', the company may have less detailed public disclosures compared to larger firms, potentially limiting investor transparency.
- The inherent risks associated with being a smaller, growing company, including potential market volatility and the challenges of scaling operations.
- The company's reliance on its EGC and Smaller Reporting Company status for operational flexibility, which could change as it grows and exceeds certain financial thresholds.
Why This Matters
This annual report provides a crucial snapshot of Wellgistics Health, Inc.'s financial and operational health for the year ending December 31, 2025. For investors, understanding this report is fundamental to assessing the company's current trajectory and future potential. It offers insights into how the company performed, which is essential for making informed investment decisions and evaluating its market position.
The classifications as a 'Smaller reporting company' and an 'Emerging growth company' are particularly significant. These designations indicate that Wellgistics is still in a growth phase and benefits from reduced regulatory burdens. While this flexibility can streamline operations and potentially reduce overhead, it also means investors might have less detailed financial information compared to larger, more established firms, requiring a closer look at available data and a higher degree of due diligence.
Key metrics like the $27.1 million public float and 105.85 million shares outstanding provide a basis for market valuation and understanding liquidity. These figures, combined with the company's NASDAQ listing, help investors gauge its market presence, the potential for capital appreciation, and inherent risks associated with its current size and reporting status.
Financial Metrics
Learn More
About This Analysis
AI-powered summary derived from the original SEC filing.
Document Information
SEC Filing
View Original DocumentAnalysis Processed
March 21, 2026 at 09:31 AM
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.